Jura Health Welcomed by Colorado Medicaid as an Approved Provider for Testing for Suspected Rare Diseases
Jura Health’s Emerge™ Platform provides whole genome sequencing (WGS), genetic counseling, and next step support; providing a personalized plan for individuals facing the complexities of rare genetic disorders. The average time to a diagnosis for a rare disease patient is 5 years. Jura Health aims to reduce that to 1 month. This Medicaid expansion ensures that more people in Colorado can access essential diagnostic and support services that can significantly improve their care journey.
“We are thrilled to have Medicaid approval in Colorado,” said Chris Moore, CEO of Jura Health. “This milestone is a first step toward our goal of making advanced genetic testing and counseling available across the country, especially to those in underserved communities. Early and accurate diagnosis can change the trajectory of a patient’s journey with a rare disease and now more families can benefit from our services without the burden of financial barriers.”
